Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the schedule hereto:
Schedule
Product: Viramune
Active Ingredient(s): Nevirapine hemihydrate 10.35mg/mL
Dosage Form: Oral suspension
NZ Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer(s): Roxane Laboratories Inc, Columbus, Ohio, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 24th day of February 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).